Inactive Instrument

Other languages Advanced Proteome Therapeutics Corp. Toronto S.E.

Equities

APC

CA0076281009

Other languages

Unlock all the news: Be the first to know and act before the market!

Canadian Investment Regulatory Organization Trading Halt - APC.H	12-05
Advanced Proteome Therapeutics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2023	30/06/23
Advanced Proteome Therapeutics Corporation Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2023	28/03/23
Spin off	15/03/23	FA
IIROC Trading Resumption - APC	17/01/23
IIROC Trading Halt - APC	17/01/23
Advanced Proteome Therapeutics Corporation agreed to Spin-Off Linceis Capital Corp.	16/01/23
Advanced Proteome Therapeutics Corporation announced that it has received CAD 0.0725 million in funding from Conation Capital	22/12/22
Advanced Proteome Therapeutics Corporation Reports Earnings Results for the First Quarter Ended October 31, 2022	21/12/22
Advanced Proteome Therapeutics Corporation Appoints Mr. Cory Brandolini to the Board of Directors	20/11/22
Advanced Proteome Therapeutics Corporation Auditor Raises 'Going Concern' Doubt	14/11/22
Advanced Proteome Therapeutics Corporation Reports Earnings Results for the Full Year Ended July 31, 2022	14/11/22
ADVANCED PROTEOME THERAPEUTICS RECEIVES ISSUED PATENT	04/08/22
Advanced Proteome Therapeutics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2022	28/06/22
Advanced Proteome Therapeutics up 28.5%, Receives Notice of Allowance for Patent Claims	13/04/22
Advanced Proteome Therapeutics Receives Notice of Allowance for Patent Claims	13/04/22
Advanced Proteome Therapeutics Corporation Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2022	25/03/22
Advanced Proteome Therapeutics Corporation Reports Earnings Results for the First Quarter Ended October 31, 2021	17/12/21
Advanced Proteome Therapeutics Corporation Auditor Raises 'Going Concern' Doubt	28/11/21
Advanced Proteome Therapeutics Corporation Reports Earnings Results for the Full Year Ended July 31, 2021	28/11/21

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Advanced Proteome Therapeutics Corp. Toronto S.E.

Equities

APC

CA0076281009

Other languages

Filters